Y-4

Clinical trials for Y-4 explained in plain language.

Never miss a new study

Get alerted when new Y-4 trials appear

Sign up with your email to follow new studies for Y-4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill aims to ease lingering shingles pain

Symptom relief Recruiting now

This study tests a new drug called Y-4 for people with long-term nerve pain after shingles (postherpetic neuralgia). About 160 adults will take either Y-4 or the standard drug pregabalin for 14 weeks. Researchers will check if Y-4 reduces daily pain better and is safe to use.

Matched conditions: Y-4

Phase: PHASE2 • Sponsor: Neurodawn Pharmaceutical Co., Ltd. • Aim: Symptom relief

Last updated Jun 12, 2026 12:07 UTC

Y-4

Get alerted when new Y-4 trials appear

New pill aims to ease lingering shingles pain